Precision Biosciences Inc (DTIL)

Jun 03, 2025

precision biosciences reports voting outcomes at annual shareholder meeting - Investing.com Australia

Jun 03, 2025

Jun 03, 2025

Precision BioSciences Holds Annual Stockholder Meeting - TipRanks

Jun 03, 2025

May 21, 2025

Precision BioSciences (DTIL): Rating Reaffirmed at Buy with $60 Target | DTIL Stock News - GuruFocus

May 21, 2025

May 19, 2025

(DTIL) Proactive Strategies - news.stocktradersdaily.com

May 19, 2025

May 16, 2025

Precision BioSciences: Q1 Earnings Snapshot - CT Insider

May 16, 2025

May 16, 2025

Precision BioSciences Reports Q1 2025 Financial Results - TipRanks

May 16, 2025

May 15, 2025

Transcript : Precision BioSciences, Inc.Special Call - marketscreener.com

May 15, 2025

May 15, 2025

Precision BioSciences Inc Reports Q1 2025 EPS of $(2.21) and Rev - GuruFocus

May 15, 2025

May 15, 2025

Precision BioSciences Reports Q1 Results and Business Update - TipRanks

May 15, 2025

May 15, 2025

Precision BioSciences (DTIL) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

May 15, 2025

May 15, 2025

Precision BioSciences (DTIL) Reports Robust Q1 Revenue and Advan - GuruFocus

May 15, 2025

May 15, 2025

Precision BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update - BioSpace

May 15, 2025

May 15, 2025

Precision BioSciences Reports First Quarter 2025 Financial Resul - GuruFocus

May 15, 2025

May 15, 2025

DTIL Reports Strong Start to 2025 with Clinical Progress | DTIL Stock News - GuruFocus

May 15, 2025

May 15, 2025

Precision BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update | DTIL Stock News - GuruFocus

May 15, 2025

May 15, 2025

Precision Biosciences Q1 Income From Operations USD -22.112 Million - marketscreener.com

May 15, 2025

May 15, 2025

Precision BioSciences (DTIL) Reports Robust Q1 Revenue and Advances Clinical Trials | DTIL Stock News - GuruFocus

May 15, 2025

May 14, 2025

Precision BioSciences Accelerates Development of PBGENE-DMD Within its Wholly Owned Organic Pipeline and Highlights Pre-clinical Evidence at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - BioSpace

May 14, 2025

May 14, 2025

Precision BioSciences Accelerates PBGENE-DMD Program for DMD - TipRanks

May 14, 2025

May 14, 2025

Precision BioSciences Accelerates Development of PBGENE-DMD With - GuruFocus

May 14, 2025

May 14, 2025

Anti-CD152 Antibody Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | Precision Biosciences, TG Therapeutics, RemeGen, Caribou Biosciences - Barchart.com

May 14, 2025

May 08, 2025

Precision BioSciences to Report First Quarter 2025 Results on May 15, 2025 - BioSpace

May 08, 2025

May 08, 2025

Precision BioSciences to Report First Quarter 2025 Results on May 15, 2025 | DTIL Stock News - GuruFocus

May 08, 2025

May 07, 2025

Precision BioSciences Announces Presentation of Initial Safety Data from the Phase 1 ELIMINATE-B Trial Evaluating PBGENE-HBV at the 2025 European Association for the Study of the Liver Congress (EASL) - GuruFocus

May 07, 2025

May 06, 2025

iECURE to Present Initial OTC-HOPE Clinical Data of ECUR-506 in Ornithine Transcarbamylase Deficiency at Upcoming Medical Meetings - Business Wire

May 06, 2025

May 01, 2025

Precision BioSciences Announces Multiple Presentations for In Vivo Gene Editing Programs at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - BioSpace

May 01, 2025

May 01, 2025

Precision BioSciences Announces Multiple Presentations for In Vivo Gene Editing Programs at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting | DTIL Stock News - GuruFocus

May 01, 2025

Apr 29, 2025

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) April 29, 2025 - BioSpace

Apr 29, 2025

Apr 29, 2025

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com

Apr 29, 2025

Apr 29, 2025

Precision BioSciences Strengthens Gene Editing Team with Strategic RSU Awards to New Hires - Stock Titan

Apr 29, 2025

Apr 23, 2025

Trading (DTIL) With Integrated Risk Controls - news.stocktradersdaily.com

Apr 23, 2025

Apr 16, 2025

DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up - TradingView

Apr 16, 2025

Apr 16, 2025

Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B | DTIL Stock News - GuruFocus

Apr 16, 2025

Apr 15, 2025

FDA fast tracks Precision BioSciences’ hepatitis B treatment By Investing.com - Investing.com South Africa

Apr 15, 2025

Apr 15, 2025

Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B - BioSpace

Apr 15, 2025

Apr 15, 2025

Precision BioSciences stock rises following FDA Fast Track designation By Investing.com - Investing.com India

Apr 15, 2025

Apr 15, 2025

Precision BioSciences Gets FDA Fast Track Label for PBGENE-HBV - marketscreener.com

Apr 15, 2025

Apr 15, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Apr 15, 2025

Apr 15, 2025

FDA Fast Tracks Precision BioSciences' (DTIL) Hepatitis B Gene E - GuruFocus

Apr 15, 2025

Apr 15, 2025

FDA fast tracks Precision BioSciences’ hepatitis B treatment - Investing.com Australia

Apr 15, 2025

Apr 15, 2025

Precision BioSciences stock rises following FDA Fast Track designation - Investing.com Australia

Apr 15, 2025

Apr 15, 2025

FDA Fast Tracks Precision BioSciences' (DTIL) Hepatitis B Gene Editing Program | DTIL Stock News - GuruFocus

Apr 15, 2025

Apr 15, 2025

Precision Biosciences Receives U.S. FDA Fast Track Designation For Pbgene-Hbv - marketscreener.com

Apr 15, 2025